Myasthenia gravis is an autoimmune disease that affects the way the muscles receive messages from the nerves, causing muscle weakness and fatigue. One of the treatments that has been shown to help improve the symptoms of myasthenia gravis is thymectomy, the surgical removal of the thymus gland. The thymus is located in the upper part of the chest and has a critical role in the development of the immune system during the first years of life. However, in some people with myasthenia gravis, the thymus can produce antibodies that attack the neuromuscular synapses, causing the symptoms of the disease. Thymectomy can be performed through open surgery or with minimally invasive techniques such as thoracoscopic (VATS) and robotic (RATS) surgery. Minimally invasive methods offer the advantages of shorter hospital stay, less post-operative pain and faster recovery. The decision to submit to a thymectomy is made after a coherent evaluation of the symptoms, the patient's age, and other factors that require careful evaluation by a specialist Neurologist. It is important to discuss the potential risks and benefits with your doctor before surgery. The aim is to improve the patient's quality of life by reducing or eliminating the symptoms of myasthenia gravis.
After thymectomy, many patients experience significant improvement in myasthenia gravis symptoms. Improvement in symptoms can take anywhere from a few weeks to months, during which time the patient will need to follow the doctor's instructions for proper care of the surgery area and management of any pain. It is also important that patients continue to work with their healthcare team to monitor and manage myasthenia gravis after thymectomy.
The success of thymectomy, as well as the speed and quality of recovery, depends on many factors, including early diagnosis, proper preparation for the operation, and patient compliance with postoperative care instructions. It is also critical to continue close follow-up and collaboration with the medical team after surgery, to prevent and promptly treat any complications or recurrence of symptoms.
In summary, thymectomy is an important treatment option for patients with myasthenia gravis, offering the opportunity to improve symptoms and quality of life in certain patients, usually the patient has a mediastinal tumor and myasthenia gravis resistant to drugs and even with surgical removal remain symptoms even for 2-5 years. .The decision to perform the operation should be made after careful discussion between the patient and the medical team, taking into account the benefits and possible risks. The choice of the method of operation, whether open surgery or through minimally invasive techniques, should also be made based on the needs and preferences of the patient, as well as the experience and expertise of the medical team.
English 
Ελληνικά 
Русский 
Български 
Македонски јазик 
Türkçe 